title: Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.
abstract: OBJECTIVE
  The significance of abdominal visceral fat accumulation was evaluated in Japanese men with impaired glucose tolerance (IGT).
  
  
  METHODS
  The IGT subjects (n = 123) were aged 55 +/- 9 years with a BMI of 24 +/- 3 kg/m(2). The 148 control subjects with normal glucose tolerance (NGT) were matched for age and BMI. IGT and NGT were classified according to the 1985 World Health Organization criteria. Abdominal fat distribution was analyzed by computed tomography at umbilical level. Plasma lipid, glucose, and insulin concentrations and blood pressure (BP) were measured.
  
  
  RESULTS
  In subjects with IGT, the average visceral fat area (VFA) was significantly greater than in subjects with NGT. Fasting insulin, the sum of insulin concentrations during an oral glucose tolerance test, insulin resistance according to a homeostasis model assessment for insulin resistance (HOMA-IR), systolic BP, and serum triglyceride were significantly higher, whereas the DeltaI(30-0)/DeltaG(30-0) was significantly lower, in subjects with IGT. Subjects with IGT and NGT were then divided into three subgroups according to the number of risk factors they possessed (dyslipidemia, hypertension, neither, or both). In both IGT and NGT subjects, BMI, VFA, subcutaneous fat area, fasting insulin, HOMA-IR, and insulin secretion of the homeostasis model assessment were significantly higher in the double-risk factor subgroup than in the no-risk factor subgroup, and VFA was a potent and independent variable in association with the presence of a double risk factor.
  
  
  CONCLUSIONS
  Visceral fat accumulation is a major contributor for multiple risk factor clustering in Japanese men with IGT and NGT.
authors.affiliation: Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Nagaretani
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: T
authors.initials: T
authors.lastname: Funahashi
authors.forename: K
authors.initials: K
authors.lastname: Kotani
authors.forename: M
authors.initials: M
authors.lastname: Miyanaga
authors.forename: K
authors.initials: K
authors.lastname: Tokunaga
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: H
authors.initials: H
authors.lastname: Nishizawa
authors.forename: K
authors.initials: K
authors.lastname: Kishida
authors.forename: H
authors.initials: H
authors.lastname: Kuriyama
authors.forename: K
authors.initials: K
authors.lastname: Hotta
authors.forename: S
authors.initials: S
authors.lastname: Yamashita
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuzawa
mesh_terms: D000273:Adipose Tissue; D001794:Blood Pressure; D001823:Body Composition; D005215:Fasting; D018149:Glucose Intolerance; D005951:Glucose Tolerance Test; D006706:Homeostasis; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007328:Insulin / Q000097:blood / Q000378:metabolism; D007333:Insulin Resistance; D000078790:Insulin Secretion; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D014781:Viscera
chemical_list: D007328:Insulin; D014280:Triglycerides